院内感染性肺炎(HAP)(Hospital Acquired Pneumonia)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hospital Acquired Pneumonia (HAP) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hospital Acquired Pneumonia (HAP) 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Cubist Pharmaceuticals, Inc. 35
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Evolva Holding SA 38
Clinical Trial Overview of Evolva Holding SA 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
KaloBios Pharmaceuticals, Inc. 40
Clinical Trial Overview of KaloBios Pharmaceuticals, Inc. 40
Merck & Co., Inc. 41
Clinical Trial Overview of Merck & Co., Inc. 41
Janssen Pharmaceuticals, Inc. 42
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 42
Basilea Pharmaceutica AG 43
Clinical Trial Overview of Basilea Pharmaceutica AG 43
Clinical Trial Overview of Top Institutes / Government 44
University of Thessaly 44
Clinical Trial Overview of University of Thessaly 44
Prince of Songkla University 45
Clinical Trial Overview of Prince of Songkla University 45
Universite Victor Segalen Bordeaux 2 46
Clinical Trial Overview of Universite Victor Segalen Bordeaux 2 46
University of Athens 47
Clinical Trial Overview of University of Athens 47
Denver Health and Hospital Authority 48
Clinical Trial Overview of Denver Health and Hospital Authority 48
St. Joseph’s Hospital and Medical Center 49
Clinical Trial Overview of St. Joseph’s Hospital and Medical Center 49
Mahidol University 50
Clinical Trial Overview of Mahidol University 50
Arak University of Medical Sciences 51
Clinical Trial Overview of Arak University of Medical Sciences 51
Hospital Pablo Tobon Uribe 52
Clinical Trial Overview of Hospital Pablo Tobon Uribe 52
Hamedan University of Medical Sciences 53
Clinical Trial Overview of Hamedan University of Medical Sciences 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83